Status:
COMPLETED
Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)
Lead Sponsor:
Organon and Co
Conditions:
Seasonal Allergic Rhinitis
Eligibility:
All Genders
15-85 years
Phase:
PHASE3
Brief Summary
This is a study to evaluate the treatment effect of montelukast 10 mg taken in the morning, versus placebo, in patients with seasonal allergic rhinitis. Loratadine is included in the study as an activ...
Eligibility Criteria
Inclusion
- Patient has a history of seasonal allergic rhinitis that worsens during the study season
- Patient is a nonsmoker
- Patient is in good health physical and mental health
Exclusion
- Patient is hospitalized
- Patient is a woman who is \< 8 weeks postpartum or is breastfeeding
- Patient plans to move or vacation away during the study
- Patient has had any major surgery with in past 4 weeks
- Patient is a current or past abuser of alcohol or illicit drugs
Key Trial Info
Start Date :
August 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2001
Estimated Enrollment :
1079 Patients enrolled
Trial Details
Trial ID
NCT00963469
Start Date
August 1 2001
End Date
November 1 2001
Last Update
February 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.